venBio Select Advisor »

Septerna shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Septerna (SEPN) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Septerna

Tip: Access up to 7 years of quarterly data

All positions including Septerna held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Septerna by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2025-09-30 $25M 1.3M 18.81
2025-06-30 $13M 1.2M 10.57
2025-03-31 $7.7M 1.3M 5.79
2024-12-31 $25M 1.1M 22.90

More positions owned by venBio Select Advisor

Ascendis Pharma Sponsored ADR (ASND)
United Therapeutics Corp Common (UTHR)
Madrigal Pharmaceuticals Common (MDGL)
Argenx Se Sponsored ADR (ARGX)
Krystal Biotech Common (KRYS)
Arrowhead Pharmaceuticals Common (ARWR)
Kymera Therapeutics Common (KYMR)
Merus N V Common (MRUS)
Avidity Biosciences Common (RNA)
Apellis Pharmaceuticals Common (APLS)
Centessa Pharmaceuticals Sponsored Adr (CNTA)
Uniqure Nv Common (QURE)
Xenon Pharmaceuticals Common (XENE)
Akero Therapeutics Common (AKRO)
Vera Therapeutics Common (VERA)

View all positions for venBio Select Advisor

Top funds holding Septerna

RA Capital Management
TRV GP V
Driehaus Capital Management
Trv Gp Vi
BVF
Samsara BioCapital
Siren
Vanguard Group
BlackRock
Goldman Sachs Group
venBio Select Advisor
ADAR1 Capital Management
VR Adviser
Casdin Capital
Geode Capital Management

View all funds holding Septerna